Systech Launches TraceIQ, Helping Transform Pharmaceutical Traceability from Compliance to Operational Intelligence

Systech’s new TraceIQ platform uses AI-enhanced analytics to turn pharmaceutical serialization data into real-time operational decision support across supply chains.

Rhea-AI Summary

Dover (DOV), through its Systech brand within Markem-Imaje, launched Systech TraceIQ, an enterprise pharmaceutical traceability platform designed to extend serialization beyond regulatory compliance into operational intelligence.

TraceIQ combines core compliance functions with an AI-assisted analytics layer, aiming to turn transaction records into actionable insights. It is structured around three goals: preventing issues before they affect production, resolving exceptions before they cause disruptions, and converting traceability data into faster, better operational decisions across supply chain, quality and compliance teams.

The platform is already in production with customers and is being demonstrated at the Healthcare Distribution Alliance Traceability Seminar in Washington, D.C., from August 31 to September 2, 2026. Systech contributes more than 40 years of packaging and serialization expertise as a brand of Markem-Imaje and part of Dover, which reports annual revenue of over $8 billion and employs approximately 24,000 people.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DOWNERS GROVE, Ill., Sept. 2, 2026 /PRNewswire/ -- Systech, part of Markem-Imaje and Dover and a leading provider of pharmaceutical serialization and traceability solutions, today announced the launch of Systech TraceIQ™, an intelligent and intuitive enterprise traceability platform created for a new operational reality in pharmaceutical supply chains.

Backed by Systech's four decades of packaging execution and serialization expertise, TraceIQ combines core compliance capabilities with an operational intelligence layer enhanced by AI-assisted analytics designed for today's pharmaceutical supply chains.

User-friendly and fast to deploy, TraceIQ transforms traceability data from a passive record of transactions into an active source of insight, enabling teams to identify patterns, investigate root causes and collaborate more effectively with partners.

"Serialization created unprecedented visibility into pharmaceutical supply chains, but visibility alone does not solve operational issues," said Sreedhar Patnala, General Manager, Systech. "Organizations need to quickly understand what happened, why it happened and what action to take next. TraceIQ helps teams move beyond compliance reporting to make proactive, informed decisions that keep products moving throughout the supply chain safely and in a timely manner."

Systech TraceIQ is built around three operational outcomes:

1. Prevent issues before they impact production: Built-in validation and guardrails help identify bad data and avoidable errors before they create downstream exceptions, rework or shipment delays.
2. Resolve exceptions before they become disruptions: Centralized traceability data and AI-assisted investigation help teams determine what happened, identify likely causes and take corrective action faster.
3. Turn traceability data into operational decisions: Intuitive search, analytics and intelligent assistance provide supply chain, quality and compliance teams with the insights needed to make quicker decisions, improve partner collaboration and optimize performance.

From emerging biopharmaceutical companies preparing for commercial launch to global manufacturers and contract organizations managing complex partner ecosystems, TraceIQ helps organizations move beyond compliance and unlock greater value from their serialization and traceability investments through greater operational visibility and increased productivity.

Systech TraceIQ is in production with customers and is being showcased in live demonstrations at the Healthcare Distribution Alliance (HDA) Traceability Seminar in Washington, D.C., from August 31 to September 2, 2026. Learn more about TraceIQ here.

About Systech:

Systech is a trusted provider of pharmaceutical track and trace solutions, bringing more than 40 years of expertise from the packaging line to the broader supply chain. Built on deep line-level experience, its integrated hardware and proven software solutions help reduce operational friction, improve efficiency, strengthen compliance and protect product integrity. With a perspective shaped by the realities of packaging, serialization, inspection and traceability, Systech partners with manufacturers of all sizes to build connected, modern supply chains that drive productivity and operational excellence. Systech is a leading brand of Markem-Imaje and a part of Dover Corporation. Visit www.systechone.com for further information.

About Markem-Imaje:

Markem-Imaje, a wholly owned subsidiary of Dover Corporation, connects products and protects brands through intelligent identification, traceability and consumer engagement solutions. We offer the industry's most comprehensive range of marking and coding systems seamlessly integrated with trusted software, services and consumables. Over 50,000 customers worldwide partner with us to help them unlock the power of information in codes. With decades of proven expertise provided through the most extensive global network, we empower our customers to optimize supply chain efficiencies, achieve sustainability and compliance objectives, keep products safe and engage their consumers. This is intelligence, beyond the mark. Visit www.markem-imaje.com for further information.

About Dover:

Dover is a diversified global manufacturer and solutions provider with annual revenue of over $8 billion. We deliver innovative equipment and components, consumable supplies, aftermarket parts, software and digital solutions, and support services through five operating segments: Engineered Products, Clean Energy & Fueling, Imaging & Identification, Pumps & Process Solutions and Climate & Sustainability Technologies. Dover combines global scale with operational agility to lead the markets we serve. Recognized for our entrepreneurial approach for over 70 years, our team of approximately 24,000 employees takes an ownership mindset, collaborating with customers to redefine what's possible. Headquartered in Downers Grove, Illinois, Dover trades on the New York Stock Exchange under "DOV." Additional information is available at dovercorporation.com.

Systech Contact:
Lou Ann Hodges
(609) 395-8400
pr@systechone.com

Dover Media Contact:
Adrian Sakowicz, VP, Communications
(630) 743-5039
asakowicz@dovercorp.com

Dover Investor Contact:
Jack Dickens, VP, Investor Relations
(630) 743-2566
jdickens@dovercorp.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/systech-launches-traceiq-helping-transform-pharmaceutical-traceability-from-compliance-to-operational-intelligence-302867901.html

SOURCE Dover

FAQ

What did Systech announce about TraceIQ for Dover (DOV)?

Systech announced the launch of Systech TraceIQ, an enterprise pharmaceutical traceability platform. It is designed to extend serialization systems from basic regulatory compliance reporting to operational intelligence, using AI-assisted analytics and centralized data to support faster, better supply chain decisions.

What are the main capabilities of Systech TraceIQ for pharmaceutical traceability?

Systech TraceIQ combines core compliance features with AI-assisted analytics, intuitive search and intelligent assistance. It focuses on preventing issues before they impact production, resolving exceptions before they become disruptions, and converting traceability data into practical operational decisions for supply chain, quality and compliance teams.

How does TraceIQ help pharmaceutical companies move beyond compliance reporting?

The company states that TraceIQ transforms traceability data from a passive transaction record into an active insight source. Teams can identify patterns, investigate root causes and collaborate with partners more effectively, enabling proactive, informed decisions that keep products moving safely and on time through the supply chain.

Who is Systech TraceIQ intended for within the pharmaceutical industry?

TraceIQ is aimed at emerging biopharmaceutical companies preparing for commercial launch as well as global manufacturers and contract organizations. It is designed for organizations managing complex partner ecosystems that want to gain more operational visibility and productivity from their serialization and traceability investments.

When and where is Systech TraceIQ being demonstrated?

Systech TraceIQ is in production with customers and is showcased in live demonstrations at the Healthcare Distribution Alliance (HDA) Traceability Seminar in Washington, D.C., held from August 31 to September 2, 2026, highlighting its capabilities to industry participants.

How is Systech related to Markem-Imaje and Dover (DOV)?

Systech is a brand of Markem-Imaje and part of Dover. Markem-Imaje is a wholly owned subsidiary of Dover, which is a diversified global manufacturer and solutions provider with annual revenue of over $8 billion and approximately 24,000 employees worldwide.